Xu Gang, Zhang Yuan-Fang, Ding Qiang
Department of Urology, Shanghai Huashan Hospital, Fudan University, Shanghai 200040, China.
Acta Pharmacol Sin. 2003 Jun;24(6):615-8.
To evaluate the efficacy and safety of Prostant in the treatment of chronic prostatitis.
One hundred and nineteen cases of patients who had been diagnosed of chronic prostatitis were treated by Prostant. The efficacy was evaluated by WBC in EPS and NIH Chronic Prostatitis Symptom Index after a one-month follow-up.
After the one-month follow-up, the total improvement rate is 65.5 %, the WBC in the prostatic fluid were reduced from (21+/-20) to (12+/-13)/High-power field (HPF); the symptom index score changed from 12+/-4 to 7+/-5. The pain and voiding score of the symptom index were lowered from 8+/-3 to 5+/-3 and 3.9+/-2.7 to 2.3+/-2.3 respectively. All of above showed great statistic differences (P<0.05). Only 2 cases (1.7 %) reported serious diarrhea.
The Prostant is effective and safe in the treatment of chronic prostatitis, especially on those cases whose symptom and inflammation in prostatic fluid are not too serious.
